Seaport Therapeutics SPTX Operating lease right-of-use asset amortization
Operating lease right-of-use asset amortization at other companies
Other financials
Where this comes from
Reported directly by Seaport Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense.
The official record: Seaport Therapeutics ’s 10-Q, filed June 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Seaport Therapeutics 's operating lease right-of-use asset amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Seaport Therapeutics 's operating lease right-of-use asset amortization?
- Seaport Therapeutics (SPTX) reported operating lease right-of-use asset amortization of $331K in Q1 2026.